Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

7.190 -0.290 (-3.88%)
Streaming Delayed Price Updated: 11:36 AM EDT, Mar 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Merck Collaborates Ginkgo Bioworks to Improve Active Pharmaceutical Ingredient Manufacturing
Via Benzinga
What Is Going on With Vox Royalty (VOXR) Stock Today?
Vox Royalty (VOXR) stock is seeing incredibly volatile trading on Tuesday after the company uplisted shares to the Nasdaq Exchange. 
Via InvestorPlace
Why Is Laser Photonics (LASE) Stock Up 55% Today?
Laser Photonics (LASE) stock is taking off on Tuesday after the company revealed a new order from the U.S. Navy to be filled this month. 
Via InvestorPlace
What Is Going on With Ginkgo Bioworks (DNA) Stock Today?
Ginkgo's planned collab with a pharma giant should spark a rally in DNA stock - but then, sometimes logic doesn't prevail on Wall Street. 
Via InvestorPlace
5 Top Stocks Cathie Wood Is Buying This Week
Ark Invest is making headlines again. Cathie Wood continues to purchase more shares of companies like Tesla despite headwinds. 
Via InvestorPlace
2 Growth Stocks That Could Rocket 80% to 102% Higher, According to Wall Street
Analysts expect these stocks to rise more than 100% once the rest of the market sees their underlying businesses in the same light. 
Via The Motley Fool
Co-founders Keep Buying Ginkgo Bioworks (DNA) Stock
Three co-founders of Ginkgo Bioworks, including CEO Jason Kelly, have filed updated forms detailing their increased stakes in DNA stock. 
Via InvestorPlace
Cathie Wood Favorite Ginkgo Bioworks Bolsters Biosecurity Platform Via This Acquisition
Via Benzinga
Analyzing Ginkgo Bioworks Holdings's Short Interest
Ginkgo Bioworks Holdings's (NYSE:DNA) short percent of float has fallen 8.12% since its last report. The company recently reported that it has 187.61 million shares sold short, which is 25.02% of all... 
Via Benzinga
Cathie Wood Keeps Buying Ginkgo Bioworks (DNA) Stock
The famed investor who focuses on disruptive technologies has been buying DNA stock hand-over-fist in recent days. 
Via InvestorPlace
Why Is Ginkgo Bioworks Stock Up Today?
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher Tuesday after the company announced the acquisitions of Altar and Circularis. Terms of the deals were not disclosed.  
Via Benzinga
5 Top Stocks Cathie Wood Is Buying This Week
There's a new Ark fund in town, and its name is the ARK Venture Fund. It will capitalize on democratizing private investments to the public. 
Via InvestorPlace
Netflix, Biogen And Other Big Gainers From Wednesday
U.S. stocks closed higher with the Dow Jones surging more than 500 points on Wednesday. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial... 
Via Benzinga
Cramer Warns Investor To Avoid This Entire Industry: 'I Do Not Want You To Touch Any Of These Stocks'
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended selling Everbridge Inc (NASDAQ: EVBG) as it does not make money. 
Via Benzinga
Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session
Gainers 
Via Benzinga
Peering Into Ginkgo Bioworks Holdings's Recent Short Interest
Ginkgo Bioworks Holdings's (NYSE:DNA) short percent of float has risen 24.11% since its last report. The company recently reported that it has 179.06 million shares sold short... 
Via Benzinga
5 Top Stocks Cathie Wood Is Buying This Week
Cathie Wood's Ark Invest had an active week of buying shares in companies like DKNG and TDOC. Investors are intrigued by Cathie Wood stocks. 
Via InvestorPlace
Don’t Jump Into the Deepening Financial Hole with Ginkgo Bioworks
You don't have to mimic Wood's trades, as DNA stock could continue its downward trajectory due to Ginkgo Bioworks' imperfect financials. 
Via InvestorPlace
5 Cathie Wood Stocks Signaling “The Bear Market Is Over”
These top Cathie Wood stocks are signalling that the bear market is over. For savvy investors, that presents a chance to profit. 
Via InvestorPlace
Wayfair, Bed Bath & Beyond And Other Big Losers From Friday
U.S. stocks closed lower with the Nasdaq Composite dropping 260 points on Friday. Here is the list of some big stocks moving lower in the previous session. 
Via Benzinga
Cathie Wood Is Doubling Down on Ginkgo Bioworks (DNA) Stock
Notorious ARK Fund Manager Cathie Wood has continued her investment into Ginkgo Bioworks this week. Despite this, DNA stock is down today. 
Via InvestorPlace
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday
Gainers 
Via Benzinga
This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday
Gainers Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter hearing aids. 
Via Benzinga
Walmart, Gap, Nordstrom And Some Other Big Stocks Recording Gains On Tuesday
U.S. stocks closed mostly higher on Tuesday, with the Dow Jones gaining around 240 points. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
Why Is FuboTV (FUBO) Stock Up 55% Today?
FuboTV (FUBO) stock is rising higher on Tuesday after the company announced an update to its leadership team. 
Via InvestorPlace
What Is Going on With Ginkgo Bioworks (DNA) Stock Today?
Ginkgo Bioworks is trending today after crushing its Q2 earnings call this morning. DNA stock is up more than 10% on strong revenue growth. 
Via InvestorPlace
Raymond James Maintains Outperform Rating for Ginkgo Bioworks Holdings: Here's What You Need To Know
  Raymond James has decided to maintain its Outperform rating of Ginkgo Bioworks Holdings (NYSE:DNA) and raise its price target from $11.50 to $14.50. Shares of Ginkgo Bioworks Holdings are trading up... 
Via Benzinga
Why GreenBox POS Is Trading Higher By Around 72%, Here Are 70 Stocks Moving In Tuesday's Mid-Day Session
Gainers GreenBox POS (NASDAQ: GBOX) shares jumped 72.4% to $2.19 as the company reported better-than-expected Q2 sales. 
Via Benzinga
Why Ginkgo Bioworks Stock Is Soaring Today
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher Tuesday after the company reported strong financial results and raised full-year guidance above analyst estimates. 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.